Occurrence of multiresistant strains of Pseudomonas aeruginosa producing metallo-β-lactamase blaSPM-1 in clinical samples;Ocorrência de cepas de Pseudomonas aeruginosa multirresistentes produtoras de metalo-β-lactamase blaSPM-1 em amostras clínicas

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 41, Issue 3, 2008, Pages 306-308

  Gräf, Tiago ^a   Fuentefria, Daiane Bopp ^a   Corção, Gertrudes ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Instituto de Ciencias Biologicas e da Saude Pontifical Catholic University of Minas Gerais   (Brazil)

Author keywords

Carbapenemases; Metallo lactamases; Multiresistance; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; TIMENTIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; DISK DIFFUSION; ENZYME SYNTHESIS; HOSPITAL; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA;

BETA-LACTAMASES; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; PHENOTYPE; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA;

PSEUDOMONAS AERUGINOSA;

EID: 50149090856     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822008000300017     Document Type: Article

References (11)

1. Arakawa Y, Shibata N, Shibayama K, Kurokawa H, Yagi T, Fujiwara H, Goto M. Convenient Test for Screening Metallo-β-Lactamase-Producing Gram-Negative Bacteria by using Thiol Compounds. Journal of Clinical Microbiology 38: 40-43, 2000.
2. GIM-1, Encoding a New Subclass of Metallo-β-lactamase. Antimicrobial Agents Chemotherapy 48: 4654-4661, 2004.
3. Clinical and Laboratory Standards Institute. M100-S17. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA, 2007.
4. IPM-1 genes of metalo- -lactamases in clinical isolates of Pseudomonas aeruginosa from three universitary hospitals in the city of Porto Alegre, Brazil. Brazilian Journal of Microbiology 38: 108-109, 2007.
5. VIM, a new integron-borne metallo-β-lactamse gene from a Pseudomonas aeruginosa clinical isolate. Antimicrobial Agents and Chemotherapy 43: 1584-1590, 1999.
6. Lee K, Lim YS, Young D, Yum JH, Chong Y. Evaluation of the Hodge Test and the Imipenem-EDTA Double-Disk Synergy Test for Differentiating Metallo-β-Lactamase-Producing Isolates of Pseudomonas spp. and Acinetobacter spp. Journal of Clinical Microbiology 41: 4623-4629, 2003.
7. Loureiro MM, Moraes BA, Mendonça VLF, Quadra MRR, Pinheiro GS, Asensi MD. Pseudomonas aeruginosa: Study of antibiotic resistance and molecular typing in hospital infection cases in a neonatal intensive care unit from Rio de Janeiro city, Brazil. Memórias do Instituto Oswaldo Cruz 97: 387-394, 2002.
8. Sader HS, Castanheira M, Mendes RE, Toleman M, Walsh TR, Jones RN. Dissemination ans diversity of metallo-β-lactamases in Latin America: report from the SENTRY antimicrobial surveillance program. International of Journal of Antimicrobiology Agents 25: 57-61, 2004.
9. Sader HS, Reis AO, Silbert S, Gales AC. IMPs, VIMs and SPMs: the diversity of metallo-β-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital. Clinical Microbiology and Infection 11: 73-76, 2004.
10. Spilker T, Coenye T, Vandame P, Lipuma JJ. PCR-Based Assay for Differentiation of Pseudomonas aeruginosa from Other Pseudomonas Species Recovered from Cystic Fibrosis Patients. Journal of Clinical Microbiology 42: 2074-2079, 2004.
11. Toleman MA, Simm AM, Murphy TA, Gales AC, Biedenbach DJ, Jones RN, Walsh TR. Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. Journal of Antimicrobial Chemotherapy 37: 673-679, 1996.